Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

141 ARTÍCULOS , VIENDO DEL 76 AL 90

Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects

Laske C, Fallgatter AJ, Stransky E, Hagen K, Berg D, Maetzler W.

Dement Geriatr Cogn Disord. 2011;31(6):413-6. doi: 10.1159/000329763. Epub 2011 Jul 13.

Alzheimer's disease

Brody H.

Nature. 2011 Jul 13;475(7355):S1. doi: 10.1038/475S1a.

[Application of mass spectrometry-based chromatographic technologies in the diagnosis of Alzheimer's disease]

Wang D, Xin G, Shi Z, Chen J, Li P.

Se Pu. 2011 Apr;29(4):293-7. doi: 10.3724/sp.j.1123.2011.00293.

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Lladó A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O'Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schröder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K.

Alzheimers Dement. 2011 Jul;7(4):386-395.e6. doi: 10.1016/j.jalz.2011.05.2243.

FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease

Platt B, Welch A, Riedel G.

Biochem Soc Trans. 2011 Aug;39(4):874-80. doi: 10.1042/BST0390874.

[Serum anticholinergic activity: relationship with clinical symptoms in Alzheimer's disease and proposal of new biological marker]

Hori K, Konishi K, Hachisu M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):135-40.

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR Jr, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative.

Acta Neuropathol. 2011 Oct;122(4):401-13. doi: 10.1007/s00401-011-0861-8. Epub 2011 Jul 30.

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications

Ferreira LK, Busatto GF.

Clinics (Sao Paulo). 2011;66 Suppl 1(Suppl 1):19-24. doi: 10.1590/s1807-59322011001300003.

Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use

Frisoni GB, Winblad B, O'Brien JT.

Int Psychogeriatr. 2011 Oct;23(8):1191-6. doi: 10.1017/S1041610211001220. Epub 2011 Aug 4.

Utility of imaging for nutritional intervention studies in Alzheimer's disease

de Wilde MC, Kamphuis PJ, Sijben JW, Scheltens P.

Eur J Pharmacol. 2011 Sep;668 Suppl 1:S59-69. doi: 10.1016/j.ejphar.2011.07.011. Epub 2011 Jul 27.

Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?

Lewczuk P, Kornhuber J.

Expert Rev Proteomics. 2011 Aug;8(4):447-58. doi: 10.1586/epr.11.37.

Evidence for ordering of Alzheimer disease biomarkers

Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Dec;68(12):1526-35. doi: 10.1001/archneurol.2011.183. Epub 2011 Aug 8.

Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease

Mosconi L, de Leon M, Murray J, E L, Lu J, Javier E, McHugh P, Swerdlow RH.

J Alzheimers Dis. 2011;27(3):483-90. doi: 10.3233/JAD-2011-110866.

Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease

Oliveira SM, Ribeiro CA, Cardoso I, Saraiva MJ.

J Alzheimers Dis. 2011;27(2):429-39. doi: 10.3233/JAD-2011-110488.

CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease

Aerts MB, Esselink RA, Claassen JA, Abdo WF, Bloem BR, Verbeek MM.

J Alzheimers Dis. 2011;27(2):377-84. doi: 10.3233/JAD-2011-110482.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias